| ABRDN SICAV I-EMERGING MARKETS SMALLER COMPANIES FUND A ACC GBP | RVI EMERGENTES | 37,29% | 64,71% | 44,63% | 104,96% |
| CINVEST MULTIGESTION / ESTUDIOS VALUE | RVI GLOBAL VALOR | 37,29% | 53,47% | 91,90% | · |
| DWS INVEST ARTIFICIAL INTELLIGENCE TFCH (P) | TMT | 37,29% | 101,93% | 49,96% | · |
| SCHRODER ISF EMERGING EUROPE IZ ACC EUR | RVI EMERGENTES EUROPA | 37,29% | · | -1,67% | · |
| BARINGS EASTERN EUROPE FUND A EUR INC | RVI EMERGENTES EUROPA | 37,28% | · | · | · |
| BARINGS EASTERN EUROPE FUND A USD INC | RVI EMERGENTES EUROPA | 37,28% | · | · | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 37,28% | 5,62% | -38,63% | · |
| SABADELL BOLSAS EMERGENTES, FI PYME | RVI EMERGENTES | 37,28% | 46,60% | 33,02% | · |
| AXA WORLD FUNDS-EMERGING MARKETS RESPONSIBLE EQUITY QI E CAP EUR | RVI EMERGENTES | 37,26% | 51,43% | 9,54% | 68,64% |
| T.ROWE GLOBAL VALUE EQUITY FUND A (HKD) | RVI GLOBAL VALOR | 37,26% | 66,03% | · | · |
